What due diligence should a buyer complete before signing a softgel contract manufacturing agreement?

Audit line-level traceability documentation for animal-derived inputs, confirm nitrogen-flush packaging capability, and request three years of batch-rejection data. Contracts lacking a defined technology-transfer exit clause typically add six months to any future supplier switch. [14] Read More

How does the Softgel Capsule Market handle cross-linking risk in dissolution testing?

Aldehyde-driven cross-linking can fail dissolution without affecting actual bioavailability. Regulators accept two-tier enzymatic testing when properly justified, and formulators increasingly specify low-aldehyde polyethylene glycol grades at the raw-material stage. [2] Read More

Which cost lines move most when switching shells in the Softgel Capsule Market?

Shell material cost rises roughly 25–40% moving from gelatin to plant polymers, though shorter drying-tunnel residence partially offsets throughput loss. Validation and stability re-testing dominate the first-year budget. [3] Read More

Is contract capacity in the Softgel Capsule Market currently tight?

High-potency and vegetarian lines are booked well ahead, while commodity gelatin capacity remains comparatively available. Buyers specifying non-animal shells should plan on nine to twelve-month qualification lead times. [15] Read More

What packaging choices matter most for oxidation-sensitive fills?

Aluminium-aluminium blisters outperform HDPE bottles on peroxide control. Nitrogen headspace flushing at fill, combined with desiccant inserts, extends usable shelf life by roughly one-third in accelerated stability studies. [18] Read More

How should investors think about valuation multiples for encapsulators?

Pure-play encapsulators generally trade below diversified contract development organisations because fill complexity is more replicable. Premiums attach to sites holding both regulated-drug and supplement approvals under one quality system. [16] Read More

What integration challenges follow a softgel plant acquisition?

Melt recipes and ribbon-spread settings rarely transfer cleanly between sites, even with identical equipment. Expect six to nine months of comparability work before a product can be reliably dual-sourced. [22] Read More

Softgel Capsule Market (2026 - 2035)

ID: MRFR/Pharma/5998-CR 101 Pages Vikita Thakur Last Updated: September 15, 2026

Softgel Capsule Market Research Report By Application (Nutraceuticals, Pharmaceuticals, Cosmetics, Vitamins, Dietary Supplements), By Ingredients (Gelatin, Fish Gelatin, Vegetable Gelatin, Active Ingredients, Colorants), By Formulation (Single Phase, Multi-Phase, Emulsified, Suspended, Gelled), By Distribution Channel (Online Retail, Pharmacies, Health Stores, Supermarkets, Direct Sales) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Softgel Capsule Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)6.3%

2025 Market SizeUSD 9.48 Billion

2035 Market SizeUSD 17.39 Billion

Key Players

Catalent, Inc.

Aenova Group

Procaps Group

Sirio Pharma

Captek Softgel International

ACG Group

Trends

Preventive Health Spending Reshapes Volume Demand
Non-Animal Shells Move From Pilot to Production
Bioavailability Economics for Lipid Formulations

Opportunities

Enteric and Delayed-Release Softgels
Emerging-Market Domestic Supply
Cosmeceutical and Topical Softgels

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Summary |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Key Report Takeaways |
1. 2.1 By Shell Source |
2. 2.2 By Application |
3. 2.3 By Geography
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2025) |
2. 3.2 Current & Forecast Market Size (2026–2035) |
3. 3.3 Year-over-Year Growth Analysis
4 Driver Impact Analysis |
1. 4.1 Preventive Health Spending Reshapes Volume Demand |
2. 4.2 Non-Animal Shells Move From Pilot to Production |
3. 4.3 Bioavailability Economics for Lipid Formulations |
4. 4.4 Contract Manufacturing Consolidation
5 Restraints Impact Analysis |
1. 5.1 Raw Material Exposure Remains Unhedged |
2. 5.2 Format Substitution in Consumer Health |
3. 5.3 Certification Friction in Restricted Markets
6 Opportunities |
1. 6.1 Enteric and Delayed-Release Softgels |
2. 6.2 Emerging-Market Domestic Supply |
3. 6.3 Cosmeceutical and Topical Softgels |
4. 6.4 Data-Enabled Manufacturing Services |
5. 6.5 Marine and Algal Oil Premiumisation
7 Regional Market Share & Country-Level Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Continuous Manufacturing and Inline Release |
2. 8.2 Biologics and Peptide Encapsulation |
3. 8.3 Sustainability Accounting |
4. 8.4 Supply Chain Regionalisation
9 Market Segmentation Analysis |
1. 9.1 By Shell Source | |
  1. 9.1.1 Gelatin (Animal-Based) | |
  2. 9.1.2 Non-Animal-Based |
2. 9.2 By Application | |
  1. 9.2.1 Pharmaceuticals | |
  2. 9.2.2 Nutraceuticals and Dietary Supplements | |
  3. 9.2.3 Cosmetics and Personal Care | |
  4. 9.2.4 Other Applications
10 Competitive Landscape |
1. 10.1 Market Share Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Catalent, Inc. | |
  2. 10.3.2 Aenova Group | |
  3. 10.3.3 Procaps Group | |
  4. 10.3.4 Sirio Pharma | |
  5. 10.3.5 Captek Softgel International | |
  6. 10.3.6 ACG Group | |
  7. 10.3.7 EuroCaps Ltd. | |
  8. 10.3.8 Fuji Capsule Co., Ltd. | |
  9. 10.3.9 Strides Pharma Science | |
  10. 10.3.10 Thermo Fisher Scientific (Patheon) | |
  11. 10.3.11 Baotai Pharmaceutical
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Data Sources & Citations |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Softgel Capsule Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Softgel Capsule Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis – Global Softgel Capsule Market, 2026–2035 |
TABLE 4 Restraint Impact Analysis – Global Softgel Capsule Market, 2026–2035 |
TABLE 5 Global Softgel Capsule Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Softgel Capsule Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Softgel Capsule Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Softgel Capsule Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Softgel Capsule Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Softgel Capsule Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Softgel Capsule Market Size, by Shell Source, 2021–2035 (USD Billion) |
TABLE 12 Global Softgel Capsule Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 13 North America Softgel Capsule Market Size, by Shell Source, 2021–2035 (USD Billion) |
TABLE 14 North America Softgel Capsule Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 15 Europe Softgel Capsule Market Size, by Shell Source, 2021–2035 (USD Billion) |
TABLE 16 Europe Softgel Capsule Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 17 Asia-Pacific Softgel Capsule Market Size, by Shell Source, 2021–2035 (USD Billion) |
TABLE 18 Asia-Pacific Softgel Capsule Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 19 South America Softgel Capsule Market Size, by Shell Source, 2021–2035 (USD Billion) |
TABLE 20 South America Softgel Capsule Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 21 Middle East & Africa Softgel Capsule Market Size, by Shell Source, 2021–2035 (USD Billion) |
TABLE 22 Middle East & Africa Softgel Capsule Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 23 Competitive Benchmarking Matrix – Global Softgel Capsule Market, 2026 |
TABLE 24 Company Profiles – Key Players, Global Softgel Capsule Market |
TABLE 25 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 26 Report Scope & Methodology Summary |
TABLE 27 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Global Softgel Capsule Market – Market Dynamics Overview (Drivers, Restraints, Opportunities) |
FIGURE 2 Industry Value Chain Analysis – Shell Polymer to Finished Dosage |
FIGURE 3 Porter's Five Forces Analysis – Global Softgel Capsule Market |
FIGURE 4 Global Softgel Capsule Market Size Trend, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Rate Trend, 2022–2035 (%) |
FIGURE 6 Market Share by Shell Source, 2025 vs 2035 (%) |
FIGURE 7 Market Share by Application, 2025 vs 2035 (%) |
FIGURE 8 Regional Market Share Distribution, 2025 (%) |
FIGURE 9 Regional CAGR Comparison, 2026–2035 (%) |
FIGURE 10 North America Country-Level Share Breakdown, 2025 (%) |
FIGURE 11 Asia-Pacific Country-Level Growth Comparison, 2026–2035 (%) |
FIGURE 12 Competitive Landscape – Estimated Revenue Share Ranges, 2026 |
FIGURE 13 Strategic Positioning Matrix – Capability vs Geographic Reach |
FIGURE 14 Non-Animal Shell Adoption Curve in New Product Launches, 2021–2035

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Shell Source	Gelatin (Animal-Based); Non-Animal-Based	Gelatin (Animal-Based)	Non-Animal-Based
By Application	Pharmaceuticals; Nutraceuticals and Dietary Supplements; Cosmetics and Personal Care; Other Applications	Pharmaceuticals	Nutraceuticals and Dietary Supplements
By Geography	North America; Europe; Asia-Pacific; Middle East and Africa; South America	North America	Asia-Pacific

Market Segmentation Overview

By Shell Source

Sub-Segment	Key Trend
Gelatin (Animal-Based)	Retains volume leadership on cost and validation depth, but exposed to hide and bone price cycles
Non-Animal-Based	Pullulan, starch, and hypromellose systems scale rapidly on certification and clean-label demand.

Shell chemistry now determines commercial access as much as technical performance. Encapsulators that run both animal and plant ribbon lines under one quality system capture the widest customer base, while single-chemistry sites face growing tender exclusions in Europe and the Gulf.

By Application

Sub-Segment	Key Trend
Pharmaceuticals	Lipid-based delivery for poorly soluble actives sustains premium pricing and long validation cycles.
Nutraceuticals and Dietary Supplements	Direct-to-consumer channels and preventive health spending drive the fastest volume growth.
Cosmetics and Personal Care	Single-dose twist-off formats gain traction in premium East Asian skincare.
Other Applications	Veterinary and specialty industrial fills provide steady, low-cyclicality baseload volume.

Application mix drives site economics more than any other variable. Pharmaceutical work carries higher margin and heavier compliance overhead; supplement work delivers throughput but compresses price. The most resilient operators deliberately blend both.

By Region

Sub-Segment	Key Trend
North America	Premiumisation and vegan shell retrofits within an established regulatory base.
Europe	Sustainability disclosure and clean-label reformulation reshape procurement criteria.
Asia-Pacific	Greenfield capacity and export finishing deliver the steepest growth curve.
Middle East and Africa	Halal certification and localisation policy drive import substitution
South America	Regulatory clarity in Brazil unlocks registration and retail expansion.

Regional divergence is widening rather than converging. Mature regions compete on capability and compliance depth; emerging regions compete on cost and proximity. Suppliers positioned in both tiers hold the strongest negotiating leverage through 2035.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”